These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Nonalcoholic steatohepatitis and the metabolic syndrome. Jiang J; Torok N Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830 [TBL] [Abstract][Full Text] [Related]
25. Pathogenesis of non-alcoholic steatohepatitis: human data. Edmison J; McCullough AJ Clin Liver Dis; 2007 Feb; 11(1):75-104, ix. PubMed ID: 17544973 [TBL] [Abstract][Full Text] [Related]
26. Non-alcoholic steatohepatitis and animal models: understanding the human disease. Varela-Rey M; Embade N; Ariz U; Lu SC; Mato JM; Martínez-Chantar ML Int J Biochem Cell Biol; 2009 May; 41(5):969-76. PubMed ID: 19027869 [TBL] [Abstract][Full Text] [Related]
27. Non-alcoholic steatohepatitis in children. Roberts EA Clin Liver Dis; 2007 Feb; 11(1):155-72, x. PubMed ID: 17544977 [TBL] [Abstract][Full Text] [Related]
28. [A man with non alcoholic steatohepatitis]. Tran A; Anty R Gastroenterol Clin Biol; 2003; 27(8-9):806-8. PubMed ID: 14586252 [No Abstract] [Full Text] [Related]
29. The emerging problem of nonalcoholic steatohepatitis (NASH). Portincasa P; Grattagliano I; Palmieri VO; Palasciano G Rom J Gastroenterol; 2005 Mar; 14(1):43-51. PubMed ID: 15800693 [TBL] [Abstract][Full Text] [Related]
30. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? Farrell GC J Gastroenterol Hepatol; 2003 Feb; 18(2):124-38. PubMed ID: 12542595 [TBL] [Abstract][Full Text] [Related]
31. Non-alcoholic steatohepatitis: an overview. Shifflet A; Wu GY J Formos Med Assoc; 2009 Jan; 108(1):4-12. PubMed ID: 19181602 [TBL] [Abstract][Full Text] [Related]
33. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Sorbi D; Boynton J; Lindor KD Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476 [TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. Anderson N; Borlak J Pharmacol Rev; 2008 Sep; 60(3):311-57. PubMed ID: 18922966 [TBL] [Abstract][Full Text] [Related]
35. Evaluation and management of non-alcoholic steatohepatitis. Reid BM; Sanyal AJ Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1117-22. PubMed ID: 15489568 [TBL] [Abstract][Full Text] [Related]
36. From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management. Lemoine M; Serfaty L; Capeau J Curr Opin Infect Dis; 2012 Feb; 25(1):10-6. PubMed ID: 22183113 [TBL] [Abstract][Full Text] [Related]
37. [Nonalcoholic steatohepatitis]. da Silva PM; Eliseu T; Costa MM; Bastos H; Nobre FL Acta Med Port; 1995 May; 8(5):323-7. PubMed ID: 7625233 [TBL] [Abstract][Full Text] [Related]